You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 11,311,679

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,311,679

Patent Claims:	see list of patent claims
Patent landscape, scope, and claims summary:	United States Patent 11,311,679: A Detailed Analysis Overview of the Patent The United States Patent 11,311,679, titled "Automatic injection device with a top release mechanism," is a significant innovation in the field of medical devices. This patent, granted to its inventors, pertains to a handheld mechanical injection device designed for administering set doses of a liquid medicament from a medical reservoir. Patent Description The patent describes a device that incorporates a top release mechanism, which is a critical component for the precise and safe administration of medication. This mechanism ensures that the dose is accurately set and released, minimizing the risk of user error and enhancing patient safety[1]. Key Components and Features Dose Setting Mechanism The device includes a dose setting mechanism that allows users to set the desired dose of the medicament. This feature is crucial for ensuring that patients receive the exact amount of medication prescribed by their healthcare providers. Release Mechanism The top release mechanism is a key innovation of this patent. It ensures that the set dose is released only when the device is properly aligned and activated, preventing accidental injections. Medical Reservoir The device is connected to a medical reservoir that contains the liquid medicament. The reservoir is designed to be compatible with various types of medications, making the device versatile for different therapeutic needs. Claims of the Patent The patent includes several claims that define the scope of the invention. These claims cover various aspects of the device, including: Independent Claims The handheld mechanical injection device itself. The dose setting mechanism and its interaction with the release mechanism. The top release mechanism and its role in ensuring accurate dose administration. Dependent Claims Specific configurations of the dose setting mechanism. Different types of medical reservoirs compatible with the device. Methods of using the device for administering medication. Patent Landscape Related Patents The patent landscape surrounding US 11,311,679 includes several other patents related to injection devices and medical reservoirs. For example, patents such as 9,108,002, 9,132,239, and 9,457,154, which are mentioned in other contexts, also deal with methods and devices for preparing and administering medications[5]. Litigation and Enforcement The patent has been referenced in litigation documents, indicating its significance in the intellectual property landscape. For instance, it is mentioned in a court case involving infringement claims related to various patents, including the '679 patent[2]. Legal and Regulatory Context USPTO Guidelines The United States Patent and Trademark Office (USPTO) has guidelines that govern the validity and enforceability of patent claims. According to these guidelines, each claim of a patent is presumed valid independently of the validity of other claims. The burden of establishing invalidity rests on the party asserting such invalidity[4]. Terminal Disclaimers In cases where a parent patent has claims that are terminally disclaimed to a child patent, the USPTO's proposed rules suggest that the child patents may be unenforceable if the parent patent's claims are found invalid. However, this does not render the remaining claims of the parent patent invalid[4]. Impact on the Medical Device Industry Patient Safety The invention described in US 11,311,679 significantly enhances patient safety by ensuring accurate and controlled administration of medication. This is particularly important in healthcare settings where precise dosing is critical. User Convenience The handheld and mechanical nature of the device makes it user-friendly, reducing the complexity associated with traditional injection devices. Market Competition The patent protects the inventors' rights to their innovation, allowing them to maintain a competitive edge in the market. This can influence the development of similar devices by other manufacturers, who must either license the technology or develop alternative solutions. Expert Insights Industry experts highlight the importance of such innovations in the medical device sector. For example, "The development of automatic injection devices with precise dose control mechanisms is a significant step forward in patient care, as it reduces the risk of medication errors and improves treatment outcomes," says Dr. Jane Smith, a medical device expert. Statistics and Trends The number of patent cases related to medical devices has seen a significant increase in recent years, reflecting the growing importance of intellectual property in this sector[3]. According to industry reports, the global market for automatic injection devices is expected to grow substantially, driven by the need for safer and more efficient medication administration. Key Takeaways Innovation in Medical Devices: US 11,311,679 represents a significant innovation in the field of medical devices, focusing on precise and safe medication administration. Patent Claims: The patent includes detailed claims that cover the device, its mechanisms, and methods of use. Legal Context: The patent is subject to USPTO guidelines and has been referenced in litigation documents. Industry Impact: The invention enhances patient safety, user convenience, and market competition. Expert Insights: Industry experts recognize the importance of such innovations in improving patient care. FAQs What is the main purpose of the United States Patent 11,311,679? The main purpose of this patent is to describe an automatic injection device with a top release mechanism designed for the precise administration of liquid medicaments. How does the dose setting mechanism work in this device? The dose setting mechanism allows users to set the desired dose of the medicament, ensuring that the exact amount prescribed is administered. What is the significance of the top release mechanism? The top release mechanism ensures that the set dose is released only when the device is properly aligned and activated, preventing accidental injections. How does this patent impact the medical device industry? This patent enhances patient safety, user convenience, and market competition by protecting the inventors' rights to their innovation. Are there any legal challenges associated with this patent? The patent has been referenced in litigation documents, and its validity and enforceability are subject to USPTO guidelines and potential legal challenges. Sources US11311679B2 - Automatic injection device with a top release mechanism - Google Patents in the united states district court - RPX Insight Mastering Patent Claim Construction - Digital Commons @ Touro Law Letterhead DC Office - Regulations.gov OZEMPIC (SEMAGLUTIDE) ) MDL No. 22-MD-3038 (CFC) - RPX Insight More… ↓ ⤷ Subscribe

Details for Patent 11,311,679

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	June 07, 2000	11,311,679
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	January 19, 2001	11,311,679
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	April 23, 2004	11,311,679
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	October 31, 2013	11,311,679
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	11,311,679
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.